David P. Nowotnik

Director/Board Member at

TheraTarget, Inc.

77 year

Health Technology

Consumer Services

Profile

David P.
Nowotnik is currently a Director at TheraTarget, Inc. He was previously a Senior Director-Product Development at Guilford Pharmaceuticals, Inc. from 1994 to 1998.
He also held the position of Senior Vice President-Research & Development at Abeona Therapeutics, Inc. Dr. Nowotnik earned a doctorate degree from the University of London.

David P. Nowotnik active positions

Companies	Position	Start
TheraTarget, Inc. TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical drug delivery company which develops polymer-drug conjugates	Director/Board Member	-

All active positions of David P. Nowotnik

Former positions of David P. Nowotnik

Companies	Position	End
Guilford Pharmaceuticals, Inc. Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases	Corporate Officer/Principal	1997-12-31
ABEONA THERAPEUTICS INC.	Corporate Officer/Principal	-

See the detail of David P. Nowotnik's experience

Training of David P. Nowotnik

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David P. Nowotnik's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Abeona Therapeutics, Inc. Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases	Health Technology
Guilford Pharmaceuticals, Inc. Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases	Health Technology
University of London University of London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
TheraTarget, Inc. TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical drug delivery company which develops polymer-drug conjugates	Health Technology